U.S. FDA Approves ‘Brexpiprazole’ as Adjunctive Treatment for Adults with Major Depressive Disorder and as a Treatment for Adults with Schizophrenia

http://www.businesswire.com/news/home/20150710005794/en/U.S.-FDA-Approves-Otsuka-Lundbeck%E2%80%99s-REXULTI%C2%AE-Brexpiprazole#.VaCNLHO6bqA

image

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s